Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center — New York, New York

Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies.

Sponsors: Leap Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center?

Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center conducted?

Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center has 1 clinical trials on record. Their work covers Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies.

Is Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center accredited by Crixeo Health?

Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Immunotherapeutics Core / Memorial Sloan Kettering Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.